NW-301V Clinical Trials
3 recruitingDrug
Phase 13
Showing 1–3 of 3 trials
Recruiting
Phase 1
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Tumor, Solid
Ting Deng9 enrolled1 locationNCT06484790
Recruiting
Phase 1
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Tumor, Solid
TingBo Liang9 enrolled1 locationNCT06478251
Recruiting
Phase 1
T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Tumor, Solid
Tao Zhang9 enrolled2 locationsNCT06484556